humans
science for
Arena BioWorks is focused on human biology, with a mission to understand mechanisms of disease in the context of human physiology and to translate those insights into new medicines that impact human health.
Arena was established to build human biology-based biotech companies that transform medicine by overcoming inherent inefficiencies in the current ecosystem.
Unmet medical needs are tackled through the collaboration of five in-house Platforms in a rigorous, efficient, disciplined, and modality-agnostic manner. These multi-platform capabilities seamlessly power every stage from mechanism to medicine.
Pathologies: therapeutic hypotheses based on human evidence in the areas of oncology, immune disease, genetic disease, brain health, and aging
Pilots: pilot projects akin to seed-funded companies with potential to become portfolio companies
PortCos: portfolio companies formed at an advanced, derisked, and high-value stage
Arena’s visionary founding investors are strategic contributors who accelerate progress by aligning with scientists to share expertise, networks and opportunities.
Arena’s visionary founding investors are strategic contributors who accelerate progress by aligning with scientists to share expertise, networks and opportunities.
news
News
ENDPOINTS FIRESIDE CHAT | 04/03/2024
Arena co-founder Stuart Schreiber chatted with senior science correspondent Ryan Cross to talk about new models for research, the small molecule revolution, and more.
CHEMICAL & ENGINEERING NEWS | 01/17/2024
Broad Institute cofounder Schreiber leaves to launch new research institution Arena BioWorks
BOSTON GLOBE | 01/12/2024
New biomedical institute launching in Cambridge to speed drug discovery
ENDPOINTS NEWS | 01/12/2024
The Bell Labs of Biotech: Stuart Schreiber has billionaire support for new biomedical institute
PRESS RELEASE | 01/12/2024
Arena BioWorks Launches as a Privately Funded, Fully Independent Biomedical Institute to Shorten the Path from Insight to Therapeutics